He received his degree in Pharmacy in 2018 and completed a PhD in Drug Development and Evaluation of Advanced Therapies at the University of the Basque Country (UPV/EHU) in 2023. His doctoral research, titled "Mesenchymal stromal cells-based sustainable strategies for wound management form valorized cell delivery systems to cell-free therapies", was awarded Cum Laude and the Extraordinary Doctorate Prize. During his academic career, he spent a research period at the University of Illinois at Chicago (UIC), focusing on advanced therapeutic approaches in regenerative medicine.

His expertise spans several innovative fields, including regenerative medicine, inflammatory diseases, and the application of biomaterials in advanced therapies. He has extensively worked with stem cells, extracellular vesicles, and bioengineered scaffolds, focusing on their integration for therapeutic use. His contributions include the design and evaluation of novel drug delivery systems and advanced formulations to improve tissue regeneration and modulate immune responses in chronic inflammatory conditions. His work also delves into the development of biomaterials optimized for cellular growth, controlled release systems, and advanced manufacturing techniques such as 3D bioprinting.

He has authored 10 scientific articles, with some featured in prestigious journals such as Journal of Controlled release, Nature Materials etc. highlighting the significance and impact of his research.

Currently, he is dedicated to the development of advanced pharmaceuticals and therapies, applying his expertise to create innovative solutions for unmet medical needs. With over five years of experience in cutting-edge research and development, he continues to contribute to the progress of pharmaceutical sciences and advanced medicine.